Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013

Payer Strategies for Emerging Markets

30 Jul 2013 - 01 Aug 2013 - Philadelphia, PA, USA

Bookmark and Share

Emerging markets are moving up the agenda of pharma and global healthcare organizations. Yet many regions are still unchartered territory and are difficult to navigate. To build effective strategic partnerships and drive the most profitable performance, you need to understand the dynamics that make these regions so challenging, yet full of potential...

That means the payers. What they need.  How they need it.  When they need it.

Payer Strategies for Emerging Markets will set you up to execute the most successful product launches in the world’s key growth markets.  Learn to manage the transformation of your traditional pharmaceutical business model to one that really takes hold in the world’s key growth economies.

This meeting will provide you with the clarity you need to demonstrate maximum product value to payers in emerging markets. The agenda has been designed in collaboration with leaders from organizations like Pfizer, Abbott, World Bank, Novartis, Merck and the World Health Organization.

Build solid payer-industry partnerships at this highly interactive forum. Payer Strategies for Emerging Markets was created for you to meet the key stakeholders who can give you the gold standard business intelligence to adapt your market access approach in different regions.

Meet pharma, payer organizations and key solution providers. This meeting lets you use these relationships to refine your product launch strategy and strengthen the foundation for commercial success in emerging markets.

At the meeting you will…

Gain an insight into regional price containment strategies. Avoid the hurdles to maximize impact at product launch

Ensure maximum patient compliance.  Find out how to best engage with an out of pocket payer in a changing health economic environment

Keep early value demonstration front of mind when preparing healthcare authorities for your product hitting the market

Develop actionable pricing and reimbursement strategies for streamlined access in emerging markets

Adapt your marketing approach and design your distribution strategies to meet the needs of both the public and private payer for long-term, regional, profitable success

Discover the benefits of local and corporate team integration to avoid a culture clash when accessing emerging markets

Understand the importance of a clear launch strategy for optimal product development and distribution in emerging markets

Payer Strategies for Emerging Markets will equip you with the knowledge and tools to boost business in key growth economies.  Get an understanding of the payers and develop unique strategies to adapt and optimize your access approach in emerging markets.

Who you’ll meet…

Pharmaceutical Companies: Heads of Marketing, Pricing, Reimbursement, Medical Affairs and Market Access looking to partner with payers and plan developers to optimize reimbursement and build strategic relationships

Payers and Plan Developers: Group Directors and Managers looking to gain a more thorough understanding of the access and pricing environment and form strategic partnerships with pharma

Market Access Consultancies: Vice President of Sales and Marketing and Directors of Business Development keen to generate new business, successfully collaborate with industry leaders and stay front-of-mind when pharma look to source consultants

Further information
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos